FOSUN PHARMA has released details regarding the selection form for the merger plan of Shanghai HENLIUS Biotechnology Co., Ltd. This form is applicable to qualified Shareholders and is used to select either a cash option or a share option.The form includes registered Shareholder information, selection type, signature栏, and other content. Shareholders choosing the share option are required to provide additional documentation for verification. The form also contains important information regarding the selection points, personal data collection statement, and more.The company reminds Shareholders to carefully read the instructions in the comprehensive document and the selection form and to submit a fully completed form before the selection deadline. Overseas Shareholders must comply with legal requirements in their respective jurisdictions. The offeror reserves the right to refuse forms that are not correctly completed or to treat them as valid. The selections submitted by Shareholders are irrevocable.

FOSUN PHARMA has released details regarding the selection form for the merger plan of Shanghai HENLIUS Biotechnology Co., Ltd. This form is applicable to qualified Shareholders and is used to select either a cash option or a share option.The form includes registered Shareholder information, selection type, signature栏, and other content. Shareholders choosing the share option are required to provide additional documentation for verification. The form also contains important information regarding the selection points, personal data collection statement, and more.The company reminds Shareholders to carefully read the instructions in the comprehensive document and the selection form and to submit a fully completed form before the selection deadline. Overseas Shareholders must comply with legal requirements in their respective jurisdictions. The offeror reserves the right to refuse forms that are not correctly completed or to treat them as valid. The selections submitted by Shareholders are irrevocable.